hepat
c
viru
hcv
caus
chronic
hepat
cirrhosi
hepatocellular
carcinoma
hcc
approxim
million
infect
peopl
worldwid
therapeut
prophylact
vaccin
current
avail
therefor
hcv
continu
repres
signific
public
health
problem
mandat
intensifi
effort
invest
clinic
manag
research
hcv
belong
hepaciviru
genu
flavivirida
famili
plusstrand
rna
viru
genom
approxim
kb
contain
singl
open
read
frame
orf
encod
singl
polyprotein
precursor
amino
acid
orf
flank
untransl
region
utr
viral
protein
translat
intern
ribosom
entri
site
ire
depend
mechan
precursor
polyprotein
process
co
posttransl
cellular
viral
proteas
protein
structur
protein
core
small
membraneassoci
protein
six
nonstructur
ns
protein
outcom
hcv
infect
vari
among
individu
percentag
infect
individu
abl
clear
resolv
infect
remain
major
develop
chronic
hepat
liver
complic
viral
mechan
chronic
infect
cellular
determin
infect
clearanc
poorli
understood
mani
virus
includ
hcv
develop
sophist
mechan
evad
antagon
cellular
antivir
respons
lead
persist
andor
chronic
infect
rafmekerk
signal
pathway
one
mitogenactiv
protein
kinas
mapk
cascad
play
import
role
regul
cell
growth
differenti
surviv
transmiss
oncogen
signal
pathway
activ
varieti
stimuli
includ
growth
factor
mitogen
transform
agent
viru
infect
upon
stimul
activ
raf
kinas
activ
turn
activ
phosphoryl
substrat
cytoplasm
transloc
nucleu
phosphoryl
transcript
factor
regul
target
gene
express
mapk
also
phosphoryl
activ
kinas
term
mapkactiv
protein
kinas
includ
ribosom
kinas
mitogenand
stressactiv
kinas
mapkinteract
kinas
virus
intracellular
oblig
parasit
evolv
exploit
host
cellular
machineri
replic
mekerk
signal
pathway
play
import
role
replic
activ
mekerk
signal
cascad
enhanc
replic
virus
human
immunodefici
viru
influenza
viru
borna
diseas
viru
coronaviru
coxsakieviru
herp
simpl
viru
underli
molecular
mechan
includ
interfer
viral
translat
replic
machineri
well
host
antivir
defens
hand
activ
mekerk
signal
lead
inhibitori
effect
viru
replic
case
hepat
b
viru
hepatotrop
viru
like
hcv
induc
hepatocellular
carcinoma
infect
host
meanwhil
inhibit
hcv
replic
hcv
subgenom
replicon
cell
activ
erk
induct
interferon
ifn
stimul
gene
mek
inhibitor
abrog
inhibitori
effect
hcv
replic
also
involv
antivir
gene
induct
human
hepatoma
cell
taken
togeth
find
indic
erk
activ
induc
antivir
effect
natur
stimuli
determin
final
outcom
signal
conceiv
stimuli
erk
signal
may
differ
effect
hcv
replic
moreov
known
whether
mekerk
signal
affect
hcv
replic
therefor
studi
aim
character
role
signal
pathway
hcv
replic
product
use
hcv
subgenom
replicon
fulllength
genom
system
huh
hcv
subgenom
replicon
cell
carri
renilla
luciferas
rluc
report
describ
elsewher
maintain
dmem
supplement
fb
penicillinstreptomycinlglutamin
nonessenti
aminoacid
huh
cell
gift
dr
steve
polyak
univers
washington
seattl
huh
cell
obtain
dr
charl
rice
rockefel
univers
new
york
cell
maintain
huh
hcv
replicon
cell
except
present
cultur
medium
mab
bd
bioscienc
san
jose
ca
mab
cell
signal
technolog
danver
hcv
core
mab
affin
bioreag
golden
co
ha
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
mab
sigma
saint
loui
mo
mek
inhibitor
cell
signal
technolog
reconstitut
dmso
purchas
pbl
biomed
laboratori
piscataway
nj
reconstitut
pb
construct
pcrclone
fragment
vector
invitrogen
carlsbad
ca
obtain
dr
takaji
wakita
domin
neg
describ
elsewher
previous
construct
iresfluc
construct
iresfluc
gift
dr
nahum
sonenberg
mcgill
univers
canada
replac
polio
ire
fragment
hcv
ire
kpn
bamh
restrict
site
hcv
rluc
replicon
construct
linear
sca
purifi
transcrib
rna
transcript
kit
ambion
austin
tx
rna
transcript
treat
u
dnase
min
purifi
acid
phenol
chloroform
extract
suspend
diethylpyrocarbonatetr
water
synthes
fulllength
hcv
rna
plasmid
linear
xba
purifi
use
templat
vitro
transcript
transcrib
rna
store
aliquot
cell
plate
plate
densiti
cell
per
well
plate
densiti
cell
per
well
transfect
hcv
rna
domin
neg
construct
perform
use
lipofectamin
reagent
invitrogen
accord
manufactur
instruct
sirna
control
sirna
purchas
ambion
transfect
cell
use
oligofectamin
invitrogen
follow
manufactur
instruct
transfect
cell
wash
replac
fresh
medium
hr
transfect
cell
lysat
prepar
hr
post
transfect
standard
ripa
buffer
separ
polyacrylamidesd
gel
protein
transfer
onto
nitrocellulos
membran
probe
appropri
primari
antibodi
hrpconjug
secondari
antibodi
visual
enhanc
chemiluminesc
vwr
west
chester
pa
indic
membran
strip
reprob
mab
hcv
rluc
replicon
cell
grown
plate
treat
mek
inhibitor
solvent
dmso
hr
pretreat
solvent
pb
prior
treatment
mek
inhibitor
dmso
luciferas
assay
perform
use
renilla
luciferas
assay
kit
promega
madison
wi
accord
manufactur
instruct
experi
involv
domin
neg
construct
sirna
hcv
rluc
replicon
cell
transfect
plasmid
sirna
cultur
hr
harvest
luciferas
assay
luciferas
assay
done
triplic
result
express
differ
consid
statist
signific
p
valu
less
hcv
rluc
replicon
cell
grown
plate
treat
mek
inhibitor
andor
transfect
sirna
indic
total
rna
isol
use
invitrogen
probe
hcv
sens
antisens
probe
synthes
use
respect
templat
rna
transcript
kit
ambion
accord
manufactur
instruct
rpa
perform
bd
ribonucleas
protect
assay
kit
bd
bioscienc
describ
elsewher
briefli
total
rna
hybrid
cpm
utplabel
antisens
sens
probe
detect
plu
minusstrand
hcv
rna
respect
rna
use
intern
equal
rna
load
control
detect
cpm
utplabel
antisens
probe
protect
probe
analyz
urea
gel
visual
autoradiographi
cultur
supernat
huh
cell
transfect
hcv
rna
collect
filter
filter
concentr
time
use
centrifug
filter
unit
mw
cutoff
kda
millipor
bedford
rna
isol
concentr
supernat
use
viral
rna
mini
kit
qiagen
valencia
ca
determin
hcv
product
cell
cultur
supernat
intracellular
hcv
rna
also
isol
transfect
cell
rna
quantit
triplic
use
onestep
rtpcr
master
mix
reagent
kit
appli
biosystem
foster
citi
ca
primer
probe
describ
previous
reaction
perform
qpcr
system
stratagen
la
jolla
ca
program
min
min
cycl
sec
min
absolut
hcv
rna
level
calcul
use
vitro
transcrib
rna
standard
determin
relationship
mekerk
signal
hcv
replic
took
advantag
two
wellcharacter
wide
use
mek
inhibitor
inhibit
activ
inact
form
inhibit
activ
inact
preliminari
experi
titrat
concentr
maxim
mekerk
inhibitori
effect
littl
cytotox
confirm
optim
concentr
respect
combin
use
data
shown
use
concentr
examin
effect
inhibitor
hcv
replic
hcv
rluc
replicon
cell
compar
dmso
control
treatment
mek
inhibitor
result
signific
increas
luciferas
report
gene
activ
fig
next
determin
whether
inhibitor
affect
hcv
rna
synthesi
distinguish
plu
minusstrand
hcv
rna
synthes
perform
rnase
protect
assay
use
strandspecif
probe
use
assay
test
strand
specif
vitro
transcrib
hcv
utr
rna
plu
minuspolar
hybrid
antisens
sens
probe
found
sens
probe
detect
minusstrand
rna
antisens
probe
detect
plusstrand
rna
cross
hybrid
data
shown
treatment
inhibitor
increas
plusstrand
hcv
rna
level
fold
dmso
control
fig
slight
increas
minusstrand
hcv
rna
level
dmso
control
fig
taken
togeth
result
provid
first
evid
inhibit
mekerk
signal
enhanc
hcv
gene
express
replic
hcv
replic
inhibit
treatment
bind
cognat
receptor
activ
jakstat
signal
turn
induc
effector
mxa
guanosin
triphosphatas
dsrna
activatedprotein
kinas
synthas
account
antivir
activ
investig
whether
mek
inhibitor
enhanc
hcv
replic
antagon
wellcharacter
antivir
mechan
treat
hcv
rluc
replicon
cell
first
follow
mek
inhibitor
lysat
prepar
luciferas
report
assay
expect
treatment
alon
inhibit
luciferas
report
gene
activ
p
treatment
follow
mek
inhibitor
show
significantli
higher
luciferas
activ
compar
treatment
control
alon
p
significantli
lower
mek
inhibitor
alon
p
fig
also
determin
hcv
rna
replic
cell
treat
cell
isol
total
rna
perform
rpa
detect
plusstrand
hcv
rna
agreement
luciferas
report
gene
activ
inhibit
plusstrand
hcv
rna
synthesi
lane
fig
compar
pb
control
lane
fig
follow
mek
inhibitor
increas
plusstrand
hcv
rna
synthesi
fig
compar
plu
dmso
control
lane
fig
addit
effect
inhibitor
plusstrand
hcv
rna
synthesi
higher
inhibitor
alon
fig
find
suggest
enhanc
hcv
replic
mek
inhibitor
probabl
independ
antivir
activ
experi
conduct
cell
cultur
medium
contain
fb
like
activ
basal
mekerk
signal
thu
determin
whether
basal
level
mekerk
activ
suffici
mek
inhibitorsenhanc
hcv
replic
address
issu
cultur
hcv
rluc
replicon
cell
serumfre
medium
hr
treat
mek
inhibitor
lysat
prepar
luciferas
report
activ
assay
total
rna
isol
plusstrand
hcv
rna
detect
rpa
absenc
serum
cultur
medium
mek
inhibitor
also
significantli
increas
luciferas
report
gene
activ
compar
dmso
control
p
fig
parallel
mek
inhibitor
also
increas
plusstrand
hcv
rna
level
fig
howev
interest
note
overal
luciferas
activ
cell
cultur
fbscontain
medium
consider
higher
cell
cultur
serumfre
medium
despit
enhanc
effect
inhibitor
show
littl
differ
cell
cultur
presenc
serum
absenc
serum
fig
attribut
activ
phosphatidylinositol
akt
pathway
major
signal
pathway
involv
serumdepend
cell
surviv
growth
taken
togeth
result
suggest
prior
activ
mekerk
signal
necessari
mek
inhibitorsenhanc
hcv
replic
involv
regul
hcv
replic
ensur
mek
inhibitorsenhanc
hcv
replic
due
nonspecif
offtarget
effect
drug
test
whether
respons
effector
downstream
mek
took
advantag
domin
neg
strategi
inactiv
constitut
activ
determin
effect
hcv
replic
hcv
rluc
replicon
cell
transfect
domin
neg
construct
empti
vector
control
lysat
prepar
hr
posttransfect
luciferas
gene
activ
measur
express
domin
neg
detect
western
blot
analysi
bottom
panel
fig
b
express
domin
neg
led
significantli
higher
luciferas
report
gene
activ
compar
control
p
fig
similarli
express
domin
neg
significantli
increas
luciferas
report
gene
activ
p
fig
howev
express
domin
neg
littl
effect
luciferas
gene
activ
compar
control
p
fig
these
result
agreement
obtain
mek
inhibitor
also
support
role
hcv
replic
ascertain
involv
hcv
replic
use
sirna
strategi
knock
constitut
express
determin
effect
hcv
replic
hcv
rluc
replicon
cell
transfect
sirna
control
sirna
lysat
prepar
express
western
blot
analysi
effect
silenc
hcv
assess
measur
luciferas
gene
activ
sirna
effect
knock
constitut
express
fig
howev
knockdown
exhibit
signific
differ
luciferas
gene
activ
compar
control
sirna
p
fig
control
sirna
appear
nonspecif
effect
level
plusstrand
hcv
rna
synthesi
differ
two
transfect
fig
therefor
result
support
notion
play
signific
role
hcv
replic
found
mek
inhibitor
increas
hcv
replic
subgenom
replicon
cell
harbor
hcv
genotyp
wish
determin
whether
inhibitor
also
increas
hcv
gene
express
replic
product
genotyp
address
question
use
recent
character
infecti
genotyp
hcv
strain
transfect
huh
cell
vitro
transcrib
fulllength
rna
treat
cell
mek
inhibitor
control
dmso
western
blot
analysi
cell
lysat
show
treatment
mek
inhibitor
result
higher
hcv
core
protein
express
compar
dmso
control
fig
analysi
total
cellular
rna
realtim
rtpcr
show
treatment
mek
inhibitor
also
led
significantli
higher
level
plusstrand
hcv
rna
compar
dmso
control
p
fig
next
determin
whether
intracellular
increas
hcv
protein
rna
led
extracellular
viru
product
collect
supernat
rnatransfect
cell
treat
mek
inhibitor
dmso
control
isol
rna
supernat
quantifi
hcv
rna
supernat
realtim
rtpcr
agreement
intracellular
increas
hcv
protein
rna
synthes
treatment
mek
inhibitor
led
significantli
higher
level
extracellular
hcv
product
compar
dmso
control
p
fig
taken
togeth
result
indic
inhibit
mek
signal
increas
hcv
gene
express
product
fulllength
hcv
genom
system
therefor
point
gener
mechan
mekerk
signal
control
hcv
replic
besid
regul
target
gene
express
phosphoryl
downstream
transcript
factor
mekerk
signal
cascad
also
involv
translat
control
gene
express
direct
phosphoryl
translat
factor
thu
also
determin
whether
mek
signal
involv
regul
hcv
iresdepend
translat
test
hypothesi
construct
bicistron
report
plasmid
hcv
ire
drive
translat
firefli
luciferas
gene
renilla
luciferas
gene
translat
capdepend
mechan
fig
transfect
huh
cell
bicistron
report
treat
cell
mek
inhibitor
harvest
cell
renilla
luciferas
rluc
firefli
luciferas
fluc
activ
treatment
mek
inhibitor
significantli
increas
firefli
luciferas
report
gene
activ
ie
hcv
iresdepend
translat
compar
dmso
control
p
fig
howev
statist
signific
differ
renilla
luciferas
report
gene
activ
ie
capdepend
translat
observ
cell
treat
mek
inhibitor
dmso
p
fig
result
indic
mek
signal
also
involv
regul
hcv
ire
translat
activ
studi
took
advantag
mek
inhibitor
domin
neg
demonstr
involv
hcv
replic
hcv
subgenom
genom
system
found
blockag
mekerk
signal
mek
inhibitor
increas
hcv
gene
express
plusstrand
rna
synthesi
consist
previou
studi
studi
look
effect
inhibitor
hcv
minusstrand
rna
synthesi
found
slight
increas
find
could
well
explain
wellknown
asymmetr
natur
plu
minusstrand
hcv
rna
synthesi
hcvinfect
cell
hcv
rna
replic
start
synthesi
genomelength
neg
strand
rna
turn
serv
templat
multipl
round
nascent
positivestrand
rna
synthesi
lead
asymmetr
accumul
nearli
plusstrand
rna
everi
singl
minusstrand
rna
result
impli
mekerk
signal
pathway
play
import
role
hcv
replic
examin
rule
possibl
inhibitor
act
offtarget
produc
observ
effect
find
domin
neg
express
significantli
enhanc
hcv
replic
previou
studi
shown
disrupt
erkdepend
type
ifn
induct
break
myxoma
viru
speci
barrier
anoth
studi
also
report
neg
regul
antivir
respons
vesicular
stomat
viru
rafmek
signal
pathway
led
us
investig
whether
antagon
antivir
activ
altern
mechan
mekerk
inhibitor
produc
observ
effect
howev
found
invers
correl
antivir
activ
mek
inhibitorsenhanc
hcv
replic
argu
possibl
inhibitor
domin
neg
enhanc
hcv
replic
interf
antivir
respons
mekerk
signal
pathway
may
regul
hcv
replic
direct
indirect
phosphoryl
viral
andor
cellular
protein
case
viral
protein
exampl
phosphoryl
protein
shown
regul
hcv
replic
moreov
select
inhibit
cellular
kinas
found
invers
correl
phosphoryl
level
hcv
rna
replic
addit
protein
phosphophoryl
serin
threonin
residu
make
potenti
substrat
mek
kinas
one
studi
shown
littl
chang
level
phosphoryl
treatment
mek
kinas
inhibitor
one
demonstr
invers
correl
inhibit
mek
kinas
level
phosphoryl
hcv
replic
howev
find
domin
neg
express
enhanc
hcv
replic
clearli
suggest
effector
mek
kinasemedi
control
hcv
replic
locat
downstream
mek
kinas
therefor
futur
investig
direct
phosphoryl
mek
would
help
determin
whether
viral
direct
substrat
cellular
kinas
mekerk
signal
pathway
involv
cell
growth
prolifer
major
target
anticanc
drug
develop
hcv
induc
hepatocellular
carcinoma
infect
individu
find
studi
well
other
inhibit
mek
signal
lead
upregul
hcv
replic
rais
concern
potenti
use
inhibitor
treatment
cancer
hcvinfect
individu
led
us
evalu
outcom
mek
inhibitorsenhanc
hcv
replic
viru
product
use
recent
describ
hcv
cell
cultur
system
found
posit
correl
among
increas
hcv
protein
plusstrand
rna
accumul
cell
hcv
product
cultur
supernat
find
support
notion
target
mekerk
signal
therapeut
intervent
treat
hepatocellular
carcinoma
may
lead
acceler
hcv
pathogen
process
possibl
support
earli
report
treatment
cell
mek
kinas
inhibitor
inde
increas
infect
hcvposit
serum
mekerk
signal
pathway
regul
target
gene
express
transcript
translat
level
direct
phosphoryl
translat
factor
use
bicistron
report
system
found
mek
inhibitor
enhanc
hcv
ire
translat
activ
effect
capdepend
translat
find
consist
previou
report
support
notion
mekerk
signal
function
control
hcv
replic
hcv
translat
machineri
furthermor
find
suggest
hcv
ire
translat
machineri
specif
target
pharmacolog
agent
without
affect
host
translat
system
